are often prescribed for high cholesterol. They have been shown to reduce mortality (death) and
. Ezetimibe has reduced plaque in arteries. However, it has not been shown to reduce mortality.
Some may have a high risk for
coronary artery disease
. In this case, combination therapy may be needed to lower LDL.
Third report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). National Cholesterol Education Program website. Available at:
. Accessed December 17, 2007.
Please be aware that this information is provided to supplement the care
provided by your physician. It is neither intended nor implied to be a
substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER
IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the
advice of your physician or other qualified health provider prior to
starting any new treatment or with any questions you may have regarding a